Journey Medical Corp banner

Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 6.63 USD -4.6% Market Closed
Market Cap: $220.5m

During the last 3 months Journey Medical Corp insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on May 2, 2025 by Maraoui Claude , who sold 33.1k USD worth of DERM shares.

Last Transactions:
Benesch Joseph
$-16.5k
Maraoui Claude
$-33.1k
Alloush Ramsey
$-19.5k
Maraoui Claude
$-246.8k
Maraoui Claude
$-74.7k
Maraoui Claude
$-128.8k
Maraoui Claude
$-93.1k
Maraoui Claude
$-145.7k
Maraoui Claude
$-122k
Benesch Joseph
$-7.1k
Benesch Joseph
$-51k
Benesch Joseph
$-21.9k
Rosenwald Lindsay A Md
$+30.4k
Maraoui Claude
$+34.8k
Smith Justin Adam
$+104.1k
Rosenwald Lindsay A Md
$+68k
Benesch Joseph
$-9.2k
Paley Jeffrey
$-9.1k
Paley Jeffrey
$-958.8
Paley Jeffrey
$-7.8k
Smith Justin Adam
$+98.3k
Paley Jeffrey
$+44.7k
Paley Jeffrey
$+89.1k
Maraoui Claude
$+65.6k
Rosenwald Lindsay A Md
$+223k
Maraoui Claude
$-36.5k
Benesch Joseph
$-7.2k
Maraoui Claude
$-32.7k
Maraoui Claude
$-25k
Benesch Joseph
$-5.5k
De Paolantonio Ernest Robert
$-24.3k
De Paolantonio Ernest Robert
$-24.3k
View All Transactions

During the last 3 months Journey Medical Corp insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on May 2, 2025 by Maraoui Claude , who sold 33.1k USD worth of DERM shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
69.1k USD
3
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
0
0 USD

Journey Medical Corp
Insider Trading Chart

Journey Medical Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Journey Medical Corp
Last Insider Transactions

Global
Insiders Monitor

Journey Medical Corp
Glance View

Market Cap
220.5m USD
Industry
Pharmaceuticals

Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.

DERM Intrinsic Value
12.41 USD
Undervaluation 47%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett